Incentives to bring vaccines to market are shrinking. Drugmakers are scaling back research investments and cutting jobs.
(CNN) — The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the ...
A Rolling Stone investigation uncovered irregularities in the ethics review of a $1.6 million research grant to examine the effects of a birth dose of the hepatitis B vaccine in Guinea-Bissau ...
European regulators cleared Moderna’s first-of-its-kind vaccine as US approval remains uncertain. On Friday, Moderna’s ...
During the COVID-19 pandemic, President Donald Trump then described mRNA technology as a "modern-day miracle." HealthDay News — In a major blow to vaccine development, the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results